RS

Ramesh Sugumaran

Director Director DIN 00620951
DIN 00620951 First appointment Sep 2004 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2004
Shareholding value Locked Premium profile

About Ramesh Sugumaran

Ramesh Sugumaran has 21 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 00620951
Primary Designation Director
First Appointment 08 Sep 2004
Oldest Company Age 21 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Epoch Pharma And Research Labs Private Limited U24231TN2004PTC054166
Director 08 Sep 2004 2004 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Epoch Pharma And Research Labs Private Limited
Premium access

Shareholding and investment profile for Ramesh Sugumaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Sugumaran

Ramesh Sugumaran has 21 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Ramesh Sugumaran is associated with 0 companies as Director.

Ramesh Sugumaran has expertise in General Business.

Ramesh Sugumaran has 21 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available